Tarsus director granted RSUs and stock options
Tarsus Pharmaceuticals director Andrew D. Goldberg received new equity awards as part of his compensation for serving as a non-employee director.
Rhea-AI Filing Summary
Tarsus Pharmaceuticals director Andrew D. Goldberg received new equity awards as part of his compensation for serving as a non-employee director. He was granted 2,417 Restricted Stock Units, each representing a contingent right to receive one share of Tarsus common stock. He also received a stock option covering 3,837 shares of common stock at an exercise price of $64.34 per share. Both the RSUs and the option were granted in connection with the company’s 2026 annual meeting of stockholders and will vest in full on the one-year anniversary of the grant date, subject to his continuous board service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 6,254 shares
Grant/Award
2 txns
Insider
Goldberg Andrew D.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,837 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 2,417 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 3,837 contracts (Direct);
Restricted Stock Units — 2,417 contracts (Direct)
Footnotes (3)
- F1. Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
- F2. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- F3. RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
Key Figures
Restricted Stock Units granted: 2,417 units
Stock options granted: 3,837 options
Option exercise price: $64.34 per share
+3 more
6 metrics
Restricted Stock Units granted
2,417 units
Equity award for non-employee director service
Stock options granted
3,837 options
Annual option grant for director service
Option exercise price
$64.34 per share
Stock Option (right to buy) grant
Option expiration date
June 24, 2036
Expiration for director stock option grant
RSUs underlying shares
2,417 shares
Each RSU equals one Tarsus common share
Options underlying shares
3,837 shares
Shares subject to director stock option
Key Terms
Restricted Stock Units, Stock Option (right to buy, non-employee director, annual meeting of stockholders, +1 more
5 terms
Restricted Stock Units financial
"Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy financial
"Stock Option (right to buy) with an exercise price of $64.34 per share"
non-employee director financial
"granted in connection with the Reporting Person's service as a non-employee director"
annual meeting of stockholders financial
"as of the Company's 2026 annual meeting of stockholders"
vest in full financial
"The option will vest in full on the one-year anniversary of the date of grant"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Tarsus (TARS) report for Andrew D. Goldberg?
Tarsus reported an equity compensation grant to director Andrew D. Goldberg. He received 2,417 Restricted Stock Units and a stock option for 3,837 shares, both tied to his service as a non-employee director following the company’s 2026 annual meeting of stockholders.
How many Restricted Stock Units were granted to the Tarsus director?
Andrew D. Goldberg was granted 2,417 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Tarsus common stock, subject to vesting conditions linked to his continued service as a non-employee director on the company’s board.
What stock options did Andrew D. Goldberg receive from Tarsus (TARS)?
He received a stock option covering 3,837 shares of Tarsus common stock. The option has an exercise price of $64.34 per share and was granted as an annual option in connection with his service as a non-employee director.
When do the new Tarsus RSUs and options for Andrew D. Goldberg vest?
Both the RSUs and the stock option vest in full one year after grant. Vesting occurs on the one-year anniversary of the grant date, provided Goldberg continues to serve as a non-employee director throughout that period on Tarsus’s board.
Is Andrew D. Goldberg’s Form 4 transaction a market buy or sell of Tarsus stock?
No, the Form 4 reflects equity compensation grants, not market trades. The transactions are awards of Restricted Stock Units and stock options for board service, rather than open-market purchases or sales of Tarsus common shares.
What is the exercise price and expiration for the new Tarsus stock option grant?
The stock option has a $64.34 per share exercise price and expires in 2036. Specifically, it carries an exercise price of $64.34 and an expiration date of June 24, 2036, assuming it remains outstanding and unexercised until then.
AI-generated analysis. How Rhea-AI works. Not financial advice.
